Sarepta Therapeutics

SRPTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.772 B

$16.78 +0.00%

Close of 7 Aug 2026

Revenue

$2.20B

#1095 by revenue

Earnings

-$713.4M

Loss-making

Shares outstanding

105,627,021

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#124PERRIGOPRGO$1.78B
#125Lakefront BiotherapeuticsLKFT$1.78B
#126Sarepta TherapeuticsSRPT$1.77B
#127Ascentage Pharma Group InternationalAAPG$1.77B
#128Ani PharmaceuticalsANIP$1.76B

Where these numbers come from

Share counts and financials for Sarepta Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.